The Cystic Fibrosis Foundation has awarded up to $5.6 million to Microbion Corporation to develop a novel, inhaled antibiotic to treat drug-resistant bacterial infections in people with cystic fibrosis.
Site Search
Showing 71 - 80 of 170 results
News
|
|
1 min read
News
|
|
2 min read
News
|
|
2 min read
At a meeting hosted by the Cystic Fibrosis Foundation, private insurers, state Medicaid officials, care center providers, health experts and people with CF and their families came together to discuss innovative ways to continue improving high quality CF care on February 4.
News
|
|
2 min read
News
|
|
2 min read
News
|
|
2 min read
News
|
|
2 min read
Dr. Frank Accurso, director of cystic fibrosis clinical research at Children's Hospital Colorado and University of Colorado Denver, participated in a congressional roundtable discussion at National Jewish Health in Denver, Colorado.
News
|
|
2 min read
News
|
|
1 min read
News
|
|
1 min read